EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?

Matthias Balk, Robin Rupp, Matti Sievert, Konstantinos Mantsopoulos, Moritz Allner, Philipp Grundtner, Sarina K Mueller, Markus Eckstein, Heinrich Iro, Markus Hecht, Antoniu-Oreste Gostian

European Archives of Oto-Rhino-Laryngology · 2023

DOI: 10.1007/s00405-023-08115-5 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2023. Verfasst von Matthias Balk und 10 weiteren Autor:innen. Beteiligte Einrichtung: Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nürnberg, Department of Otolaryngology, Head & Neck Surgery, Friedrich-Alexander Univ…. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Erlangen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The following study aimed to answer the question if HPV-HNCUP and HPV-OPSCC are the same disease. Propensity score matching (PSM) was used to compare the oncological outcomes of both groups, in particular the 5-year overall survival rate (OS), the 5-year disease specific survival rate (DSS) and the 5-year progression free survival rate (PFS). Materials and methods Firstly, between January 1st, 2007, and March 31st, 2020 a total of 131 patients were treated with HNCUP at our Department. Out of these, 21 patients with a confirmed positive p16 status were referred to surgery followed by adjuvant therapy. Secondly, between January 1st, 2000, and January 31st, 2017, a total of 1596 patients were treated with an OPSSC at our Department. Out of these, 126 patients with a confirmed positive p16 status were referred to surgery followed by adjuvant therapy. After PSM, 84 patients with HPV-OPSCC and 21 HPV-HNCUP remained in the study for further comparison.

Results

The OS was 63.5% (95% CI 39.4–87.6) for HPV-HNCUP and 88.9% (95% CI 90.4–100.0) for HPV-OPSCC patients and therefore, significantly lower for the first mentioned ( p = 0.013). The DSS was also significantly impaired for HPV-HNCUP (71.0%, 95% CI 46.3–95.7), in comparison with HPV-OPSCC patients (95.5%, 95% CI 90.4–100.0; p = 0.002). The PFS for HPV-HNCUP patients was lower (75.6%, 95% CI 54.0–97.2) yet not significantly different to HPV-OPSCC (90.4%, 95% CI 83.5–97.3; p = 0.067).

Conclusions

The results presented demonstrate a significant reduced OS and DSS for HPV-HNCUP patients. Accordingly, in our study HPV-HNCUP and HPV-OPSCC are two different entities with a different oncological outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellHead and Neck NeoplasmsNeoplasms, Unknown PrimaryOropharyngeal NeoplasmsPapillomavirus InfectionsHumansPrognosisRetrospective StudiesSquamous Cell Carcinoma of Head and Neck

Stichwörter der Autor:innen

Cancer of unknown primaryHPV-HNCUPHPV-OPSCCHead and neck cancerNeck dissectionOropharyngeal cancer

Autor:innen und Institutionen

  • Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nürnberg, Department of Otolaryngology, Head & Neck Surgery, Friedrich-Alexander University Erlangen-Nürnberg (FAU), University Hospital Erlangen, Waldstra…
  • Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nürnberg, Department of Pathology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), University Hospital Erlangen, Krankenhausstraße 8-10, 91054, Erl…
  • Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nürnberg, Department of Radiation Oncology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), University Hospital Erlangen, Universitätsstraße 27, 91…

Förderung

  • Universitätsklinikum Erlangen

Zitieren

APA

Balk, M., Rupp, R., Sievert, M., Mantsopoulos, K., Allner, M., Grundtner, P., Mueller, S. K., Eckstein, M., Iro, H., Hecht, M., & Gostian, A. O. (2023). A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-023-08115-5

Vancouver

Balk M, Rupp R, Sievert M, Mantsopoulos K, Allner M, Grundtner P, et al. A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?. European Archives of Oto-Rhino-Laryngology. 2023. doi:10.1007/s00405-023-08115-5

BibTeX
@article{Balk2023,
  author = {Balk, Matthias and Rupp, Robin and Sievert, Matti and Mantsopoulos, Konstantinos and Allner, Moritz and Grundtner, Philipp and Mueller, Sarina K and Eckstein, Markus and Iro, Heinrich and Hecht, Markus and Gostian, Antoniu-Oreste},
  title = {A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2023},
  doi = {10.1007/s00405-023-08115-5}
}
Kostenlos starten →